XXII News and Press, 22nd Century Group Inc From 01/12/24

Analyst Hosted Event to Discuss Refocused Business, Cost Reductions and Turnaround Plan Buffalo, New York--(Newsfile Corp. - January 12, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII) (the "Company" or "22nd Century"), a biotechnology company focused on utilizing advanced plant technologies to ...

Sale Will Significantly Reduce Operating Expenses, Ultimately Reduce Debt by $5.2 Million Buffalo, New York--(Newsfile Corp. - December 28, 2023) - 22nd Century Group, Inc. (NASDAQ: XXII) (the "Company" or "22nd Century"), a biotechnology company focused on utilizing advanced plant technologies ...

Sale and Related Actions Ultimately Expected to Reduce Debt Principal by $5.2 Million Buffalo, New York--(Newsfile Corp. - December 14, 2023) - 22nd Century Group, Inc. (NASDAQ: XXII) (the "Company" or "22nd Century"), a biotechnology company focused on utilizing advanced plant technologies to i...

2023-12-04 09:10:25 ET More on 22nd Century 22nd Century to sell its hemp/cannabis franchise, stock jumps ~13% after hours 22nd Century Group prices public offering to raise $5.25M Seeking Alpha’s Quant Rating on 22nd Century Historical earnings data f...

BUFFALO, N.Y., Dec. 04, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII) (the “Company”), a biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced the exercise of warrants by certain holders pur...

2023-11-29 11:29:00 ET A New York-based %Pharmaceutical company is stealing the show on Wednesday following a key appointment of a new executive. According to a release this morning, %22ndCenturyGroup (Nasdaq: XXII) appointed Lawrence Firestone as chairman and CEO. This announceme...

2023-11-29 07:36:04 ET More on 22nd Century 22nd Century to sell its hemp/cannabis franchise, stock jumps ~13% after hours 22nd Century Group prices public offering to raise $5.25M Seeking Alpha’s Quant Rating on 22nd Century Historical earnings data f...

BUFFALO, N.Y., Nov. 29, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII) (“22nd Century” or the “Company”), a biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced the appointment of&...

2023-11-27 17:00:23 ET 22nd Century Group ( NASDAQ: XXII ) on Monday said it would sell all of its GVB Biopharma hemp/cannabis operations, about a year and a half after acquiring the business. XXII stock surged 12.8% to $0.24 after hours. XXII will sell the operations to...

BUFFALO, N.Y., Nov. 27, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII ) (the “Company” or “22nd Century”), a leading biotechnology company focused on utilizing advanced plant technologies to improve health and wellness, today announced it has ...